SHENZHEN, China - TelAve -- At the start of the new year, Transtek Medical (300562.SZ) celebrates a double victory. On February 6, at the 2025 High-Quality Development Conference in Zhongshan Torch Development Zone, Transtek Medical was honored with two prestigious awards—"Top 10 Enterprises in R&D Investment Contribution" and the "Bai Qian Wan Project Contribution Award"—in recognition of its outstanding technological innovation and contributions to social and economic development.

Transtek Medical Recognized as a Top 10 Enterprise in R&D Investment Contribution

This award recognizes enterprises for their outstanding commitment to R&D investment. In addition to its headquarters in Zhongshan, Transtek Medical has established R&D centers in Shenzhen, Shanghai, and other locations. This continuous investment in R&D not only strengthens the company's core competitiveness but also provides strong support for regional economic innovation and development.

More on TelAve News

• Yunishigawa Onsen's Annual "Kamakura Festival" will be held January 30 – March 1, 2026
• At Your Service Plumbing Named a 2025 Nextdoor Neighborhood Fave
• Custom Home Builder Connecticut Valley Homes Wins 2025 Home of the Year from the Modular Home Builders Association
• Scoop Social Co. Partners with Air Canada to Celebrate New Direct Flights to Milan with Custom Italian Piaggio Ape Gelato Carts
• Breakout Phase for Public Company: New Partnerships, Zero Debt, and $20 Million Growth Capital Position Company for 2026 Acceleration

Transtek Medical Honored with the "Bai Qian Wan Project Contribution Award

This award was established as part of Guangdong Province's initiative to promote regional coordination, urban-rural integration, and industrial upgrading. It recognizes enterprises that have made outstanding contributions to local economic growth, industrial transformation, and rural revitalization. Transtek Medical actively fulfills its social responsibility, demonstrating strong corporate commitment and playing a key role in driving high-quality regional economic development.

Receiving both the "Top 10 Enterprises in R&D Investment Contribution" and the "Bai Qian Wan Project Contribution Award" at the 2025 High-Quality Development Conference in the Torch Development Zone is not only a strong recognition of Transtek Medical's outstanding past performance but also a testament to the high expectations for its future growth.

Founded in 2000, Transtek is committed to multiple health fields such as remote health and chronic disease management, providing customers with medical-grade "RPM devices" and "cloud services". Transtek also provides one-stop connectivity technology, device management, and fulfillment services for Remote Patient Monitoring (RPM) providers. Transtek has established a co-branded solution named TeleRPM since 2019, it stands for Quality & Value which is the best of Transtek. TeleRPM is an integrated solution which includes cellular blood pressure monitor, cellular weight scale, cellular blood glucose meter and all-round BLE package with AnyHub solution. Also, TeleRPM is open and scalable, and Transtek will leverage their expertise to help customers realize greater value, potential and outcomes.

More on TelAve News

• Japan's Patented "Hammock'n" Smartphone Band Targets Hand Fatigue From Long Phone Use
• Reditus Group Introduces A New Empirical Model for Early-Stage B2B Growth
• CCHR: Harvard Review Exposes Institutional Corruption in Global Mental Health
• New Book: Customer loyalty is dead – telcos have been chasing a ghost
• Goatimus Launches Dynamic Context: AI Prompt Engineering Gets Smarter